|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Checkmate Pharmaceuticals (NASDAQ: CMPI) through any online brokerage.
There are no as such competitors for Checkmate Pharmaceuticals.
The latest price target for Checkmate Pharmaceuticals (NASDAQ: CMPI) was reported by Bank of America on 2020-09-01. The analyst firm set a price target for 19.00 expecting CMPI to rise to within 12 months (a possible 167.98% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Checkmate Pharmaceuticals (NASDAQ: CMPI) is $7.09 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Checkmate Pharmaceuticals. The last dividend paid out to investors was $0.00 on 2000-11-01.
There is no upcoming split for Checkmate Pharmaceuticals.